Curocell큐로셀
372320 · KOSDAQ · ₩372320 · 큐로셀
₩25,000▲ ₩600 (2.46%)End-of-day · Oct 28, 2026 · End-of-day prices.
Filings
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인신청) (CRC01(안발캅타젠오토류셀, 안발셀)의 B세포 급성 림프모구성 성인 백혈병 제1/2상 임상시험계획(IND) 변경승인신청)Oct 27, 2026Open on DART
Predicted impact: Low
Clinical trial plan change approval request; no direct financial size given.
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 21, 2026Open on DART
Predicted impact: Low
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 9, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 24, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 23, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 22, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인) (CD19 CAR-T 치료제 CRC01의 전신 홍반성 루푸스 제1,2상 임상시험계획 변경승인)Jun 16, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 2, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)May 28, 2026Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고May 27, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인신청)May 22, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 15, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 14, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)May 7, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (림카토주(안발셀) 식품의약품안전처 품목허가 승인)Apr 29, 2026Open on DART
- Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Apr 27, 2026Open on DART
- Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Apr 27, 2026Open on DART
- Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Apr 17, 2026Open on DART
- Convertible bond issue decision주요사항보고서(전환사채권발행결정)Apr 17, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 13, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 13, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 13, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 13, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 13, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 31, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 31, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 19, 2026Open on DART
- Audit report submitted감사보고서제출Mar 13, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 12, 2026Open on DART
- Occurrence of Derivatives Trading Loss파생상품거래손실발생Mar 12, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 12, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 12, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 11, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Mar 11, 2026Open on DART
- Exercise of Conversion Rights전환청구권행사Feb 24, 2026Open on DART
- Exercise of Conversion Rights전환청구권행사Feb 23, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 16, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 14, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 12, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인) (CD19 CAR-T 치료제 CRC01의 전신 홍반성 루푸스 제1,2상 임상시험계획 변경승인)Dec 9, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최Dec 5, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Nov 18, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 13, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인신청) (CD19 CAR-T 치료제 CRC01의 전신 홍반성 루푸스 제1,2상 임상시험계획 변경승인신청)Nov 3, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인) (CRC01(안발캅타젠오토류셀, 안발셀)의 B세포 급성 림프모구성 성인 백혈병 제1/2상 임상시험계획(IND) 코호트 2B 변경승인)Oct 20, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 20, 2025Open on DART
- Major sales or supply contract단일판매ㆍ공급계약체결Oct 13, 2025Open on DART
- Securities Issuance Results (Voluntary Disclosure) (3rd Convertible Bond Issue)증권발행결과(자율공시) (제3회차 CB)Sep 26, 2025Open on DART
- Convertible bond issue decision주요사항보고서(전환사채권발행결정)Sep 17, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: Curocell / 큐로셀 / 372320 / KRX:372320
Source: KRX statistical information